Download presentation
Presentation is loading. Please wait.
Published byRussell Barnard Floyd Modified over 6 years ago
1
Volume 367, Issue 9520, Pages 1399-1404 (April 2006)
Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment Kathleen M Daddario-DiCaprio, Dr Thomas W Geisbert, PhD, Ute Ströher, PhD, Joan B Geisbert, Allen Grolla, Elizabeth A Fritz, PhD, Lisa Fernando, Prof Elliott Kagan, MD, Peter B Jahrling, Lisa E Hensley, PhD, Steven M Jones, PhD, Heinz Feldmann, MD The Lancet Volume 367, Issue 9520, Pages (April 2006) DOI: /S (06) Copyright © 2006 Elsevier Ltd Terms and Conditions
2
Figure 1 Kaplan-Meier survival curves of rhesus monkeys treated with rVSV vectors after MARV challenge The Lancet , DOI: ( /S (06) ) Copyright © 2006 Elsevier Ltd Terms and Conditions
3
Figure 2 Development of neutralising antibodies in animals treated with VSVΔG/MARVGP after MARV challenge The Lancet , DOI: ( /S (06) ) Copyright © 2006 Elsevier Ltd Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.